We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

When there is only one pharmacist expected to fill, check the status, and distribute medications to patients at a busy ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health ® is the leading health solutions company ... lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow ...

CVS says a former top UnitedHealth Group executive, Steve Nelson will lead Aetna effective today. The health conglomerate is betting on an insurance-industry veteran from a company that investors have ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...

CVS Health/Morning Consult survey reveals most ... Our people and trust are the heart of everything we do, and why as we look toward the future, we're focused on ensuring a viable, sustainable ...

American Heart Association invests $1 million in digital health startup MDisrupt, connecting health tech companies with industry leaders for innovation.

CVS Health’sCVS0.49%increase; green up pointing triangle new chief executive, David Joyner, moved quickly to put his stamp on the company, promising a reorganization and new leadership at Aetna ...